PACS: Q3 growth and acquisitions underpin higher FY 2026 revenue and Adjusted EBITDA guidance

What happened

PACS reported third-quarter revenue growth of 11.5% and a 33.6% rise in Adjusted EBITDA compared with a year earlier. Adjusted earnings per share were $0.63. The company raised its full-year 2026 revenue and Adjusted EBITDA guidance to include newly acquired Florida and Texas operations.

Confirmed

Global impact / market context

Higher guidance means management expects more revenue and operating profit than previously projected, partly because the Florida and Texas purchases add sales and expenses. For investors, that can support the earnings outlook, but the added results depend on integrating those operations and keeping the operating improvements going.

Analyst inference

The update points to growth from both existing operations and acquisitions, a mix that can lift revenue and profit but also adds integration work and costs. Investors weighing the stock would focus on whether the raised outlook is backed by durable gains rather than one-time additions.

Analyst inference

What to watch

1. PACS raised its fiscal 2026 revenue and Adjusted EBITDA guidance to include the acquired Florida and Texas operations. Confirmed
2. Watch whether management discloses how much of the raised guidance comes from the acquisitions versus operating improvements. Proposed
3. Track integration costs and whether the Florida and Texas operations add revenue and profit as expected without raising expenses. Analyst inference

Evidence

• Original source link unavailable